Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sana Biotechnology, Inc. - Common Stock
(NQ:
SANA
)
4.883
-0.247 (-4.82%)
Streaming Delayed Price
Updated: 11:42 AM EST, Dec 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Sana Biotechnology, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform
Today 9:00 EST
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology to Present at December 2025 Investor Conferences
November 24, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates
November 06, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit
November 04, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology to Present at September 2025 Investor Conferences
August 26, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 20, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates
August 11, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Pricing of Public Offering
August 06, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
August 06, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes
August 04, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
June 23, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
June 09, 2025
Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1 diabetes
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology to Present at June 2025 Investor Conferences
May 28, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
May 20, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
May 18, 2025
From
Pomerantz LLP
Via
GlobeNewswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
May 18, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
SANA Deadline: Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
May 17, 2025
From
The Rosen Law Firm, P.A.
Via
Business Wire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
May 14, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
May 13, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference
May 12, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA
May 11, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
May 09, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates
May 08, 2025
From
Sana Biotechnology, Inc
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
May 05, 2025
From
Pomerantz LLP
Via
GlobeNewswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
April 30, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
April 29, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
April 26, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
April 25, 2025
From
Pomerantz LLP
Via
GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
April 23, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
ROSEN, A RANKED AND LEADING FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
April 21, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
